Han Y - Search Results

1

The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.

Nan Y, An J, Bao J, Chen H, Chen Y, Ding H, Dou X, Duan Z, Fan J, Gao Y, Han T, Han Y, Hu P, Huang Y, Huang Y, Jia J, Jiang J, Jiang Y, Li J, Li J, Li R, Li S, Li W, Li Y, Lin S, Liu J, Liu S, Lu L, Lu Q, Luo X, Ma X, Rao H, Ren H, Ren W, Shang J, Shi L, Su M, Wang B, Wang R, Wei L, Wen Z, Wu B, Wu J, Xin S, Xing H, Xu J, Yan M, Yang J, Yang J, Yang L, Yang Y, Yu Y, Zhang L, Zhang L, Zhang X, Zhang Y, Zhang Y, Zhao J, Zhao S, Zheng H, Zhou Y, Zhou Y, Zhuang H, Zuo W, Xu X, Qiao L. Nan Y, et al. Among authors: han y, han t. J Hepatol. 2021 Aug;75(2):454-461. doi: 10.1016/j.jhep.2021.05.003. Epub 2021 May 19. J Hepatol. 2021. PMID: 34019941

2

Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.

Peng D, Han Y, Ding H, Wei L. Peng D, et al. Among authors: han y. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1082-8. doi: 10.1111/j.1440-1746.2008.05478.x. J Gastroenterol Hepatol. 2008. PMID: 18707599

3

[Clinical significance of liver function and autoantibodies in patients with acute or chronic drug-induced liver injury].

Liu YM, Yan HP, Han Y, Zhang LJ, Liu Y, Liao HY, Chen YS, Huang YL, Zhao GQ, Ding HG. Liu YM, et al. Among authors: han y. Zhonghua Gan Zang Bing Za Zhi. 2010 Jan;18(1):37-40. doi: 10.3760/cma.j.issn.1007-3418.2010.01.009. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20128967 Chinese.

4

Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients.

Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, Tu C, Guo J, Zhang S, Wang J, Lu Y, Han Y, Shen L, Chen X, Hu X, Wang X, Chen C, Fu Q, Ma X. Qiu D, et al. Among authors: han y. J Hepatol. 2011 Feb;54(2):340-7. doi: 10.1016/j.jhep.2010.06.032. Epub 2010 Sep 15. J Hepatol. 2011. PMID: 21056494

5

[Comparison between two diagnostic criteria for PBC-AIH overlap syndrome].

Zhu JY, Zhou XM, Wang JH, Wang RA, Huang XF, Han ZY, Chen Y, Han Y. Zhu JY, et al. Among authors: han y, han zy. Zhonghua Gan Zang Bing Za Zhi. 2011 Feb;19(2):132-3. doi: 10.3760/cma.j.issn.1007-3418.2011.02.016. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 21492520 Chinese.

6

[Efficacy comparison between bicyclol and polyene phosphatidylcholine treatments for the patients with nonalcoholic fatty liver disease].

Su HL, Zhu YX, Gao ZJ, Dong XY, Zhu JY, Lei WR, Zhang Y, Han Y. Su HL, et al. Among authors: han y. Zhonghua Gan Zang Bing Za Zhi. 2011 Jul;19(7):552-3. doi: 10.3760/cma.j.issn.1007-3418.2011.07.019. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152250 Clinical Trial. Chinese. No abstract available.

7

Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose.

Han Y, Shi JP, Ma AL, Xu Y, Ding XD, Fan JG. Han Y, et al. Clin Drug Investig. 2014 Jan;34(1):1-7. doi: 10.1007/s40261-013-0136-3. Clin Drug Investig. 2014. PMID: 24081374 Clinical Trial.

8

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Li Y, Wang W, Tang L, He X, Yan X, Zhang X, Zhu Y, Sun J, Shi Y, Ma X, Mackay IR, Gershwin ME, Han Y, Hou J. Li Y, et al. Among authors: han y. Hepatology. 2015 Jun;61(6):1998-2007. doi: 10.1002/hep.27725. Epub 2015 Mar 18. Hepatology. 2015. PMID: 25627620 Free PMC article.

9

Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.

Chen GF, Wei L, Chen J, Duan ZP, Dou XG, Xie Q, Zhang WH, Lu LG, Fan JG, Cheng J, Wang GQ, Ren H, Wang JP, Yang XX, Jia ZS, Fu QC, Wang XJ, Shang J, Zhang YX, Han Y, Du N, Shao Q, Ji D, Li F, Li B, Liu JL, Niu XX, Wang C, Wu V, Wong A, Wang YD, Hou JL, Jia JD, Zhuang H, Lau G. Chen GF, et al. Among authors: han y. PLoS One. 2016 Jun 8;11(6):e0155934. doi: 10.1371/journal.pone.0155934. eCollection 2016. PLoS One. 2016. PMID: 27276081 Free PMC article.

10

The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis.

Han Y, Zeng A, Liao H, Liu Y, Chen Y, Ding H. Han Y, et al. Int Immunopharmacol. 2017 Jan;42:168-175. doi: 10.1016/j.intimp.2016.11.022. Epub 2016 Dec 1. Int Immunopharmacol. 2017. PMID: 27915131 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25,610 results

Search Page